Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
11.77
-0.27 (-2.24%)
At close: Nov 14, 2025, 4:00 PM EST
11.75
-0.02 (-0.17%)
After-hours: Nov 14, 2025, 4:20 PM EST
IART Stock Forecast
Stock Price Forecast
The 6 analysts that cover IART stock have a consensus rating of "Hold" and an average price target of $15, which forecasts a 27.44% increase in the stock price over the next year. The lowest target is $11 and the highest is $25.
Price Target: $15 (+27.44%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IART stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 2 | 3 |
| Sell | 3 | 3 | 3 | 3 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Reiterates $15 → $13 | Hold | Reiterates | $15 → $13 | +10.45% | Nov 3, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $12 → $11 | Strong Sell | Maintains | $12 → $11 | -6.54% | Oct 31, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $12 → $13 | Sell | Maintains | $12 → $13 | +10.45% | Oct 31, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +27.44% | Oct 15, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $10 → $12 | Strong Sell | Maintains | $10 → $12 | +1.95% | Oct 7, 2025 |
Financial Forecast
Revenue This Year
1.67B
from 1.61B
Increased by 3.51%
Revenue Next Year
1.72B
from 1.67B
Increased by 2.88%
EPS This Year
2.24
from -0.09
EPS Next Year
2.42
from 2.24
Increased by 7.79%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.8B | 1.8B | ||
| Avg | 1.7B | 1.7B | ||
| Low | 1.6B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 9.0% | 10.1% | ||
| Avg | 3.5% | 2.9% | ||
| Low | -1.0% | -3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.33 | 2.68 | ||
| Avg | 2.24 | 2.42 | ||
| Low | 2.13 | 2.22 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 19.3% | ||
| Avg | - | 7.8% | ||
| Low | - | -0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.